_2020091018165303jzv.jpg "Decoding The World Of ETF")
-
My Account
Associate Partners:
My Account
Associate Partners:
Associate Partners:
BSE Live
Jan 22, 16:00Prev. Close
2205.15
Open Price
2205.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 22, 16:00Prev. Close
2204.60
Open Price
2220.00
Bid Price (Qty.)
2284.50 (312)
Offer Price (Qty.)
0.00 (0)
Gland Pharma - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2020
The Board of Directors at its meeting held on January 22, 2021 has inter- alia approved the Unaudited Financial Results of the Company for the Quarter and Nine months ended December 31, 2020
Gland Pharma - Statement Of Investor Complaints For The Quarter Ended December 2020
| No.of Investor complaints pending at the beginning of the quarter | No.of Investor complaints received during the quarter | No.of Investor complaints disposed of during the quarter | No.of Investor complaints unresolved at the end of the quarter |
|---|---|---|---|
| 0 | 37 | 37 | 0 |
| Name of the Signatory | :- | p sampath kumar |
| Designation | :- | Company Secretary and Compliance Officer |
Gland Pharma - Shareholding for the Period Ended December 31, 2020
Gland Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
Gland Pharma - Earnings Conference Call
Earnings Call for Investors/Analysts to be held on Friday, 22nd January, 2021 at 1830 hours IST
Gland Pharma - Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice of Board Meeting - Advertisement
Gland Pharma - Board Meeting Intimation for Board Meeting Intimation For Quarterly Board Meeting
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2021 ,inter alia, to consider and approve the Unaudited financial results of the Company for the quarter and nine months ended December 31, 2020
Gland Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/ Investor meeting with Anand Rathi, Concept Investwell Pvt. Ltd. and Kotak Institutional Equities on December 26 and 28, 2020
Gland Pharma Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates
Gland Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Investor Meet with IIFL Institutional Equities on 23-Dec-2020
Gland Pharma Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates
Non
| Jan 22, 17:29
Compliances
| Jan 22, 17:28
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
| Jan 22, 17:19
Results For The Quarter Ended December 31, 2020
| Jan 22, 17:18
Compliances
| Jan 22, 17:18
Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011
| Jan 22, 17:17
Board Meeting Intimation for Approval Of The Unaudited Financial Results Of...
| Jan 22, 17:16
Record Date For Delisting Of Jaihind Projects Limited
| Jan 22, 17:15
Shareholding for the Period Ended December 31, 2020
| Jan 22, 17:14
Unaudited Consolidated And Standalone Financial Results For The Quarter Ended D...
| Jan 22, 17:13
Shareholding for the Period Ended December 31, 2020
| Jan 22, 17:13
Appointment Of Mr. Mathew Job (Currently The CEO) As Add...
| Jan 22, 17:13
Non Applicability Certificate Under Regulation 23(9) Of SEBI(LODR) Reg...
| Jan 22, 17:13
Compliances
| Jan 22, 17:12
Shareholding for the Period Ended December 31, 2020
| Jan 22, 17:12
Announcement under Regulation 30 (LODR)
| Jan 22, 17:11
Shareholding for the Period Ended December 31, 2020
| Jan 22, 17:11
Compliances
| Jan 22, 17:10
Compliances
| Jan 22, 17:09
Compliances
| Jan 22, 17:07
| Meeting Date : | Jan 22, 2021 |
| Remark : | Quarterly Results |
